Workflow
Caribou Biosciences (NasdaqGS:CRBU) Earnings Call Presentation

Positive clinical updates on Caribou's off-the-shelf CAR-T cell therapy programs: • Vispa-cel for r/r LBCL (vispacabtagene regedleucel; CB-010) • CB-011 for r/r MM N O V E M B E R 3 , 2 0 2 5 Important information Forward-looking statements This presentation contains forward-looking statements (FLS) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of known and unknown risks, assumptions, uncertainties, and other factors that ...